Treatment success rate for patients treated for MDR-TB in Mozambique
Mozambique: Treatment success rate for patients treated for MDR-TB was 77.0% in 2022. ▲ Rising
Treatment success rate for patients treated for MDR-TB in Mozambique, 2006–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in Mozambique is 77.0%, measured in 2022. That is the highest value across all 17 years on record.
The figure is up 175.0% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Mozambique peaked at 77.0% in 2021 and was at its lowest, 0.0%, in 2009.
That places Mozambique 61st out of 163 countries with data for 2022, putting it in the middle of the range.
The long-run direction has been consistently rising across the 17 years of available data.
Treatment success rate for patients treated for MDR-TB in Mozambique, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 41.0% | — |
| 2007 | 37.0% | -9.8% |
| 2008 | 36.0% | -2.7% |
| 2009 | 0.0% | -100.0% |
| 2010 | 29.0% | — |
| 2011 | 31.0% | +6.9% |
| 2012 | 28.0% | -9.7% |
| 2013 | 52.0% | +85.7% |
| 2014 | 50.0% | -3.8% |
| 2015 | 48.0% | -4.0% |
| 2016 | 50.0% | +4.2% |
| 2017 | 61.0% | +22.0% |
| 2018 | 66.0% | +8.2% |
| 2019 | 72.0% | +9.1% |
| 2020 | 75.0% | +4.2% |
| 2021 | 77.0% | +2.7% |
| 2022 | 77.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 28.5% | 0.0% | 41.0% | 4 |
| 2010s | 48.7% | 28.0% | 72.0% | 10 |
| 2020s | 76.3% | 75.0% | 77.0% | 3 |
Countries ranked near Mozambique
- 59 Venezuela, Bolivarian Republic of 78.0% compare
- 59 Bangladesh 78.0% compare
- 61 India 77.0% compare
- 61 Nepal 77.0% compare
- 64 Iraq 76.0% compare
- 64 Philippines 76.0% compare
- 64 Pakistan 76.0% compare
- 64 Guinea 76.0% compare
- 64 Lao People's Democratic Republic 76.0% compare
- 64 Nigeria 76.0% compare
More health data for Mozambique
- Un projection of annual infant deaths, annual growth rate -1.85 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.16 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 869.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18,288 deaths (2100)
- Population ages 15-19, male, annual growth rate 4.02 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0549 units per person (2025)
- Population ages 20-24, female, annual growth rate 2.11 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0465 units per person (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Mozambique?
- Treatment success rate for patients treated for mdr-tb in Mozambique was 77.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Mozambique?
- The highest recorded value was 77.0% in 2021.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Mozambique?
- The lowest recorded value was 0.0% in 2009.
- How does Mozambique rank for treatment success rate for patients treated for mdr-tb?
- Mozambique ranks 61st out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Mozambique?
- Over the last ten years it is up 175.0%. The long-run trend across the full record is rising.
- Where does this Mozambique data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).